Carmen Scheibenbogen
Carmen Scheibenbogen (born 16 March 1962) is a German immunologist who is the acting director of the Institute for Medical Immunology of the Charité university hospital in Berlin.[1][2] She specialises in hematology (blood and blood diseases), oncology and immunology.[2] She leads the Outpatient Clinic for Immunodeficiency and the Fatigue Centre at the Charité hospital.[3] She is one of the few doctors specialised in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in Germany,[4] and also researches long COVID.[1]
Career
Scheibenborgen started her study of medicine in Bonn in 1982 and finished it in Marburg. During her studies she spent half a year in Denver in the US, working in a hospital there, and developed a passion for the immune system. She continued as a research assistant at the University of Freiburg, and trained in rheumatology and hemo-oncology in Heidelberg.[5]
In 1998 she founded a group around tumor immunology at the
In 2022, she received the German Cross of Merit for her work around ME/CFS.[1] Patients and their family had put her name forward to be considered.[6]
Research
Scheibenborgen studies the role of autoimmunity in ME/CFS.[7] Her group found that in a subset of people with ME/CFS, there are autoantibodies to neurotransmitter and nuclear receptors.[8] She hypothesized in a series of papers with Klaus Wirth that autoimmunity may explain the diverse symptoms of ME/CFS in a subset of patients, including muscle weakness and the neurological symptoms.[9][10][11]
Since the start of the COVID-19 pandemic, she has researched therapeutic options for people with long COVID.[1]
Selected publications
- Leser HG, Gross V, Scheibenbogen C, et al. (September 1991). "Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis". Gastroenterology. 101 (3): 782–5. PMID 1907253.
- Nagorsen D, Scheibenbogen C, Marincola FM, et al. (October 2003). "Natural T cell immunity against cancer". Clinical Cancer Research. 9 (12): 4296–303. PMID 14555498.
- Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, Scheibenbogen C, Murovska M, Prusty BK (October 2018). "Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)". Journal of Translational Medicine. 16 (1): 268. PMID 30285773.
- Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, Scheibenbogen C (June 2018). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease". Autoimmunity Reviews. 17 (6): 601–609. PMID 29635081.
- Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, Steinbeis F, Haffke M, Rudolf G, Heidecker B, Bobbert T, Spranger J, Volk HD, Skurk C, Konietschke F, Paul F, Behrends U, Bellmann-Strobl J, Scheibenbogen C (August 2022). "A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity". Nature Communications. 13 (1): 5104. PMID 36042189.
References
- ^ a b c d Richter-Kuhlmann, Eva (4 November 2022). "Carmen Scheibenbogen: Hoffnung für Long-COVID-Erkrankte". Deutsches Ärzteblatt (in German). Deutscher Ärzteverlag GmbH, Redaktion Deutsches. Retrieved 2 January 2024.
- ^ a b "Prof. Dr. med. Carmen Scheibenbogen". Charité. Retrieved 7 January 2024.
- ^ "Internationale Konferenz: ME/CFS – eine kaum erforschte Krankheit". tagesschau.de (in German). 15 May 2023. Retrieved 2 January 2024.
- ^ "Ordensverleihung zum Tag der Deutschen Einheit". Der Bundespräsident (in German). Retrieved 5 January 2024.
- ^ a b Dotti, Anna (2 January 2023). "Porträt von Carmen Scheibenbogen". Tagesspiegel (in German). Retrieved 5 January 2024.
- ^ Hildebrandt, Stefanie (4 October 2022). "Berliner Charité-Professorin ist die einzige Hoffnung für viele Long-Covid-Erkrankte". Berliner Kurier (in German). Retrieved 26 January 2024.
- ^ Tucker, Miriam (1 September 2021). "Emerging data point to underlying autoimmunity in ME/CFS". www.mdedge.com. Retrieved 7 January 2024.
- PMID 29635081.
- PMID 32247028.
- PMID 35016692.
- PMID 33882940.
| International | |
|---|---|
| National | |
| Academics | |
